lobbying_activities: 2824527

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2824527	388f4952-ec6e-4fc1-be5d-fd3da4fe9d44	Q2	RICCHETTI INCORPORATED	62778	IPSEN BIOPHARMACEUTICALS, INC.	2022	second_quarter	PHA	Issues related to pharmaceutical industry, generally Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)	HOUSE OF REPRESENTATIVES	20000		0	0	2022-07-18T14:09:37-04:00